3Y9-18607-07175
4 vaccinations
5 coded responses
37 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 223 / VA
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 1 — Moderna
- 2021-01-18
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pruritus — Feeling: Good · Site: ItchingFree text: Itching around the injection site has been very mild/infrequent.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
- 2021-01-24
- 2021-01-25
-
2021-02-01
Survey response — day 14, dose 1MedDRA: Injection site erythema — Feeling: GoodFree text: I noticed some redness around the injection site since my last check-in; however, the redness is not currently present anymore.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
-
2021-02-15
Dose 2 — Moderna
-
2021-02-15
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Migraine — Feeling: Good · Site: Pain · HeadacheFree text: History of migraines; uncertain whether headache is related to vaccination, but may not be.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-18
- 2021-02-20
- 2021-02-24
- 2021-03-02
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-05-17
- 2021-08-16
-
2021-11-15
Dose 3 — Pfizer-BioNTech
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-15
- 2021-12-20
- 2021-12-27
- 2022-02-16
-
2022-05-19
Survey response — 6 months, dose 3MedDRA: Cough, Oropharyngeal pain, Paranasal sinus discomfort, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had symptoms including a fever, sore throat, and some congestion (sinus pressure, slight runny nose, some coughing) about a week ago. However, my PCR test (taken at the height of these symptoms) came back negative for Covid.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Dose 4 — Pfizer-BioNTech
- 2022-10-18
- 2022-10-26
- 2022-11-01
-
2022-12-19
Survey response — 3 months, dose 4MedDRA: COVID-19, Chills, Pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Currently covid positive (previous symptoms of chills, fever, body aches, etc - mostly alleviated currently).MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Moderna | |
| 2 | 2021-02-15 | Moderna | |
| 3 | 2021-11-15 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Itching around the injection site has been very mild/infrequent.
Release 3 — day 14, dose 1
Symptoms: I noticed some redness around the injection site since my last check-in; however, the redness is not currently present anymore.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): History of migraines; uncertain whether headache is related to vaccination, but may not be.
Release 11 — 6 months, dose 3
Symptoms: I had symptoms including a fever, sore throat, and some congestion (sinus pressure, slight runny nose, some coughing) about a week ago. However, my PCR test (taken at the height of these symptoms) came back negative for Covid.
Release 12 — 3 months, dose 4
Symptoms: Currently covid positive (previous symptoms of chills, fever, body aches, etc - mostly alleviated currently).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release